Continuing Education
PROGRAM DESCRIPTION: The enduring web-based conference sessions will provide the most current information on STD prevention strategies to allow STD prevention professionals to translate the latest research into practice, improve program implementation and apply the latest policies.
To obtain CE credit, go to Training and Continuing Education Online. After you register/login, search for WD2666 or 2016 STD Prevention Conference under Key Words to access credits. For more detailed instructions, see To receive continuing education (CE) below.
Click on links to view recordings of sessions.
September 20. 2016
Opening Plenary (Continuing Education: CE–PL1)
PL1. PrEPortunity for STD Controlexternal icon
Sheena McCormack, MBBS, MSc, FRCP, Dip Ven, Professor, Senior Clinical Scientist, MRC Clinical Trials Unit at UCL Institute Of Clinical Trials & Methodology Aviation House, London, UK
September 21, 2016
Plenary Session 1 (Continuing Education: CE–PL2)
PL2. Microbiome and Local Immune Responseexternal icon
The Impact of Genital Infections and the Genital Microbiome on Mucosal and Systemic Immunology
Rupert Kaul, MD, PhD, FRCP(C), Professor, University of Toronto, Toronto, ON
Molecular Tools for Studying Human Microbial Communities: Implications for STD research and Diagnostics
David Fredericks, MD, MS, BS, Member, Fred Hutchinson Cancer Research Center / Professor, University of Washington, Seattle, WA
Mini-Plenary 1 (Continuing Education: CE – A1)
A1. Transforming Old Problems into New Solutionsexternal icon
Syphilis Control in the Post-elimination Era
Matthew R. Golden, MD, MPH, BA, Director, Public Health – Seattle & King County HIV/STD Program, Professor of Medicine, University of Washington, Harborview Medical Center, Seattle, WA
Gonococcal Resistance—Perspectives from 30 years of GISP
Jonathan Zenilman, MD, BA, Professor of Medicine, Chief, Infectious Diseases Division, Johns Hopkins Bayview, Baltimore, MD
Technology Innovations in STD Prevention and Control
Patrick Sullivan, PhD, DVM, Professor, Emory University, Rollins School of Public Health, Atlanta GA
Mini-Plenary 2 (Continuing Education: CE – A2)
A2. Critical Contributors to STD Preventionexternal icon
Using a Sexual Health Approach to Improve Patient Care and Public Health
Edward W. Hook III, MD, Professor, Medicine, Microbiology and Epidemiology, University of Alabama at Birmingham, Birmingham, AL
Update on STI Vaccine Progress
Gail Bolan, MD, Director of Division of Sexually Transmitted Disease Prevention, Centers for Disease Control and Prevention, Atlanta, GA
The Transformation of American Healthcare: The Appreciation of Value
Otis W. Brawley, MD, BS, Chief Medical and Scientific Officer, American Cancer Society, Atlanta, GA
Concurrent Sessions 1A-E
B1. 1D – Symposium: Syphilis: Re–Emerging Clinical Disease and Point Of Care Testsexternal icon (Continuing Education CE–B1)
Ocular Syphilis: Seeing an Old Disease in a New Light
Shireesa Dhanireddy, MD, Associate Professor, Department of Medicine, University of Washington, Seattle, WA
Syphilis: Old Disease, New Tricks
Yetunde F. Fakile, PhD, MSc, BSc, Team Lead/ Microbiologist, Centers for Disease Control and Prevention, NCHHSTP/ DSTDP/ Laboratory Reference and Research Branch, Atlanta GA
Epidemiology and Prevention of Congenital Syphilis
Jeanne S Sheffield, MD, OB/GYN, MFM, BS, Professor, Director Maternal-Fetal Medicine, Johns Hopkins Hospital, Baltimore, MD
B2. 1E –Symposium: New Directions in Addressing Adolescent STD Riskexternal icon (Continuing Education: CE–B2)
What’s different about Detroit’s school screening program? Research aimed at explaining results showing 5 consecutive years of declines in CT prevalence
Richard Dunville, MPH, Research Officer, Centers for Disease Control and Prevention, NCHHSTP/DASH, Atlanta, GA
Prevention Opportunities through Mainstream Media: Development and Evaluation of the Hit Hulu TV Series, East Los High
Kathy Le Backes, MPH, BS, Director of Research & Development, Wise Entertainment, Santa Monica, CA
Technology and Adolescents – Opportunities for Prevention
Rachel Kachur, MPH, BA, Health Communications Specialist, Centers for Disease Control and Prevention, Atlanta, GA
Plenary Session 2: (Continuing Education: CE – PL3)
A Social Justice Approach to STD Prevention
Mary Bassett, MD, MPH, Commissioner of Health, New York City Department of Health and Mental Hygiene, Queens, NY
Poverty, Public Policy and Public Health
Sheldon Danziger, PhD, BA, President, Russell Sage Foundation, New York, NY
Concurrent Sessions 2A-F
C1: 2D–Symposium: STD/HIV Criminalization And Incarceration-Related Policies: What Is The Impact on STD Prevention?external icon (Continuing Education: CE–C1)
State Drug Policies and their Consequences: How the Criminal Justice System Can Perpetuate Social Disadvantage Among Vulnerable Populations
Cramer, Ryan, JD, MPH, Public Health Analyst, Centers for Disease Control and Prevention, Atlanta, GA
Unjust and unhealthy: the public health & human rights imperatives to end overly broad HIV/STD criminalization
Elliott, Richard, LLM, LLB, BA Hons, Executive Director, Canadian HIV/AIDS Legal Network, Toronto, ON
Qualitative Examination of Jail Policies Related to STD Prevention
LaPollo, Archana Bodas, MPH, Senior Project Director, Research and Evaluation Group, Public Health Management Corporation, Philadelphia, PA
C2. 2E–Symposium: The Role of Sexual Transmission in Non-STI Pathogensexternal icon (Continuing Education: CE – C2)
Risk reduction behavioral counseling for Ebola virus disease survivors
Neetu Abad, PhD, Behavioral Scientist, Centers for Disease Control and Prevention, Atlanta, GA
Sexual Transmission of Zika Virus – What We Know and What We Don’t Know
John T. Brooks, MD, BA, Senior Medical Advisor, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Investigating Ebola Virus in Body Fluids of Survivors in Sierra Leone: the Ebola Virus Persistence Study
Barbara Knust, DVM, MPH, Epidemiologist, Viral Special Pathogens Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA
Debate 1:
D. Should We Be doing EPT for MSM?external icon (Continuing Education: CE – D)
Jonathan Mermin, MD, MPH, AB, Director, NCHHSTP, Centers for Disease Control and Prevention, Atlanta, GA
Matthew R. Golden, MD, MPH, BA, Director, Public Health – Seattle & King County HIV/STD Program Professor of Medicine, University of Washington, Harborview Medical Center, Seattle, WA
Debate 2
E. Is it Okay if MSM get STIs, Just Not HIV?external icon (Continuing Education: CE – E)
Myron S. Cohen, MD, Director, UNC Institute for Global Health and Infectious Diseases, University of North Carolina, Institute for Global Health and Infectious Diseases, Chapel Hill, NC
Laura Hinkle Bachmann, MD, MPH, Professor of Medicine, Wake Forest University Health Sciences, Winston-Salem, NC
September 22, 2016
Plenary Session 3 (Continuing Education: CE – PL4)
PL4. Social Justice for Sexual and Racial Minoritiesexternal icon
Justice or Just Us?
Mandy Carter , Owner, Mandy Carter Consulting, Durham, NC
Sexual Rights, Social Justice and Minoritized Groups
Eleanor Maticka-Tyndale, PhD, MA, BA, Distinguished University Professor, Associate Dean Research Development, Faculty of Arts, Humanities & Social Sciences, University of Windsor, Windsor, ON, Canada
Mini-Plenary Session 3
F1. STD Prevention in the Context of Biomedical Interventions to Prevent HIV and Unintended Pregnancyexternal icon (Continuing Education: CE–F1)
HIV Pre-Exposure Prophylaxis (PrEP) and Sexually Transmitted Infections (STI)
Demetre Daskalakis, MD, MPH, BA, Assistant Commissioner, Bureau of HIV/AIDS Prevention and Control NYC Department of Health and Mental Hygiene, Long Island City, NY
The Nexus of LARC Use and STD Testing
Clare Coleman, BA, President & CEO, National Family Planning & Reproductive Health Association, Washington, DC
Preventing HIV, STI, and Unintended Pregnancy in Women at Risk: Evolving Evidence and Approach
Jeanne Marrazzo, MD, Professor of Medicine & Director, Infectious Diseases, University of Alabama Birmingham, Birmingham, AL
Mini-Plenary Session 4
F2. Understanding Gender Identity: Neurodevelopmental Underpinnings, Gender Fluidity, and Creating Better Outcomes for Sexual Minoritiesexternal icon (Continuing Education: CE– F2)
Gender Fluidity and Gender Identity Development
Aron C. Janssen M.D., Asst Prof of Child & Adolescent Psychiatry; Clinical Director NYU Gender and Sexuality Service, NYU Child Study Center, NY, NY
Transgender Populations: Epidemiology and Best Practices in STD Prevention and Care
Tonia Poteat, PhD, MPH, PA-C, MMSc, BA, Assistant Professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Impact of Social Policy on the Well-Being of LGB Populations
Ellen Riggle PhD, AM, BA, Professor, Department of Political Science, University of Kentucky, Lexington, KY
Concurrent Sessions 3A-E
G1. 3D – Symposium: Beyond Chlamydia and Gonorrhea: The Epidemiology of Less Common Sexually Transmitted Pathogensexternal icon (Continuing Education: CE – G1)
Things are Not Always as They Seem: Neisseria meningitidis-associated Urethritis
Jose A. Bazan, DO, Assistant Professor, Internal Medicine, Division of Infectious Diseases, The Ohio State University College of Medicine, Columbus, OH, Medical Director, Sexual Health Clinic, Columbus Public Health, Columbus, OH
Sex, drugs, and diarrhea: the emergence of shigellosis as a sexually transmitted disease
Anna Bowen, MD, MPH, BS, Medical Epidemiologist, CDC, Atlanta, GA
Dissecting Routes of Sexual Transmission of Hepatitis C Among HIV-Infected Men Who Have Sex With Men
Daniel Seth Fierer, MD, Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY
G2. 3E – Symposium: What does it mean to be “LGBT-Friendly”? Creating Safe and Inclusive Environments in Schools and Clinicsexternal icon (Continuing Education: CE–G2)
Shopper Methodology as Quality Assurance and Opportunity for Technical Assistance to Agencies
José A. Bauermeister, PhD, MPH, Presidential Associate Professor of Nursing, University of Pennsylvania, Philadelphia, PA
Creating safe and supportive environments for sexual and gender minority youth
Catherine N. Rasberry, PhD, MCHES, MS, BS, Health Scientist. Centers for Disease Control and Prevention, Division of Adolescent and School Health, Atlanta, GA
Creating LGBTQ welcoming clinics
Asa Radix, MD, MPH, Director of Research and Education, Callen-Lorde Community Health Center, New York City, NY
Plenary Session 4 (Continuing Education: CE–PL5)
PL5. Plenary 4: Temporal Changes in Demographic and Health Systemsexternal icon
The Role of Burden of Disease, Cost-Effectiveness and Technical Efficiency in Improved Strategic Decision-Making
Nicholas Kassebaum, MD, BA, Assistant Professor, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA
America’s Changing Population and Family Structures: Emerging Challenges for STD Prevention
Steven Martin, Ph.D., Senior Research Associate, Urban Institute Center on Labor, Human Services, and Population, Washington DC
Concurrent Sessions 4A-F
H1. 4D – Symposium: Public Health Informaticsexternal icon (Continuing Education CE–H1)
The Continuing Evolution/Maturation of Public Health Informatics and Future Directions
William Brand, MPH, Director, Public Health Informatics Science, Public Health Informatics Institute, The Task Force for Global Health, Decatur, GA
Using Grindr for Public Health
Jack Harrison-Quintana, MA, BS, Director of Grindr for Equality, Grindr, West Hollywood, CA
Evaluating a decade of automated public health surveillance using electronic health record data
Michael Klompas, MD, MPH, Associate Professor, Harvard Pilgrim Health Care Institute, Boston, MA
H2. 4E – Symposium: Innovative Models of Supporting Quality STD Careexternal icon (Continuing Education: CE–H2)
Transforming Care for LGBT People with Collaborative Learning and Telementoring
Daren Anderson, MD, Director, Wetizman Institute, Community Health Center, Inc., Weitzman Institute, Middletown, CT
Adapting Telemedicine Strategies, Meeting the Needs of Your Target Audience – High-Impact HIV Prevention, STD Clinical Issues, and Clinic Infrastructure
Bruce Maeder BA, Director, National PTC STD Curriculum Center, Seattle, WA
An Introduction to TeleHealth, including Telemedicine, Telementoring and the TeleECHO model Model to Improve Access to Quality STD Clinical Care
Bruce Baird Struminger, MD, MA, BA, Associate Director, ECHO Institute & Associate Professor of Medicine, Division of Infectious Diseases, University of New Mexico Health Sciences Center, Albuquerque, NM
Debate 3:
I. Are Use of non-microscopic BV POC tests sufficient for clinical management of BV?external icon (Continuing Education: CE–I)
Caroline Mitchell, MD, MPH, Assistant Professor, Obstetrics, Gynecology & Reproductive Biology, Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA
Jeanne Marrazzo, MD, Professor of Medicine & Director, Infectious Diseases, University of Alabama Birmingham, Birmingham, AL
Debate 4:
J. Can Alcohol Taxes Impact STD Rates?external icon (Continuing Education: CE–J)
William C. Miller, MD, PhD, MPH, AB, Professor and Chair, College of Public Health, Ohio State University, Columbus, OH
David Jernigan, PhD, AB, Associate Professor, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
September 23, 2016
Concurrent Sessions 5A-F
K1. 5D – Symposium: The Vaginal MicroEnvironment: Impact on Risk of STI Acquisitionexternal icon (Continuing Education: CE–K1)
Disruption of the Vaginal Environment and predisposition to STI acquisition
Rebecca Brotman, PhD, MPH, BA, Associate Professor, University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore, MD
Vagina and the Sex Partner
Lisa Manhart, PhD, MPH, BA, Professor, Department of Epidemiology University of Washington, Seattle, WA
Restoring a Healthy Vaginal Environment – Current Challenges and Approaches
Muzny, Christina, MD, MED, ID, Assistant Professor of Medicine, University of Alabama at Birmingham, Division of Infectious Diseases, Birmingham, AL
K2. 5E – Symposium: The Intersection of Policy, Science and Population Health: Pulling on the Levers of Industry, Economics and Political Will for STD Preventionexternal icon (Continuing Education: CE – K2)
Impact of Changing HIV policy on STD clinics in NY
Susan Blank, MD, MPH, BS, Medical Officer, New York City Department of Health and Mental Hygiene, Bureau of STD Control / Centers for Disease Control and Prevention, Long Island City, NY
How do STD preventive services compare to other evidence-based preventive interventions?
Michael V. Maciosek, PhD, Senior Research Investigator, HealthPartners Institute, Minneapolis, MN
How Should STD Prevention Address the Businesses that Affect Our Field?
Dan Wohlfeiler, MJ, MPH, BA, Director, Building Healthy Online Communities, UCSF, Richmond, CA
Concurrent Sessions 6A-E
L1. 6D – Symposium: Combating Antimicrobial Resistant Bacteria (CARB)/Advanced Molecular Detection (AMD) and Gonococcal Resistanceexternal icon (Continuing Education CE – L1)
What Is the AMD Initiative?
Gregory L. Armstrong, MD, Director, Centers for Disease Control and Prevention, Office of Advanced Molecular Detection, Atlanta, GA
CARB and resistant GC
Virginia Bowen(Ginny), PhD, MHS, Epidemiologist, Centers for Disease Control and Prevention, Division Of Sexually Transmitted Disease Prevention, Atlanta, GA
What is the CARB initiative?
Jean Patel, PhD, D(ABMM), BS, Health Scientist, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA
AMD and resistant GC
David Trees, PhD, BS, Research Microbiologist, Centers for Disease Control and Prevention, Atlanta, GA
L2. 6E – Symposium: Assessment of STDs: Moving Beyond Counting Casesexternal icon (Continuing Education CE–L2)
STD Data without Borders
Joan Chow, DrPH, MPH, BA, Chief, Surveillance, Epidemiology, Assessment & Evaluation Section, California Department of Public Health-STD Control Branch, Richmond, CA
Novel Outcomes of Interest in STD Prevention
Katherine Hsu, MD, MPH, ScB, Medical Director, Division of STD Prevention & HIV/AIDS / Associate Professor of Pediatrics, Massachusetts Department of Public Health / Boston University Medical Center, Jamaica Plain, MA
Using National Surveillance Data to Estimate the Number of Congenital Syphilis Cases Averted
Sarah Kidd, MD, MPH, BA, Medical Epidemiologist, Division of STD Prevention, CDC, Atlanta, GA
Closing Plenary (Continuing Education: CE – PL6)
PL6. Closing Plenary: Collaborative Diagnosis: Addressing the Social Determinants of Health to Improve Outcomesexternal icon
Sylvia Caley, JD, MBA, RN, BA, Associate Clinical Professor, Director, Health Law Partnership, Georgia State University College of Law, Atlanta, GA
OBJECTIVES:
At the conclusion of the session, the participant will be able to:
- Discuss at least two examples of clinical management or biomedical intervention that can enhance STD prevention and control efforts.
- Explain at least two ways STD diagnostic strategies can enhance STD prevention and control efforts.
- Discuss at least two examples of domestic or global STD-related epidemiological or behavioral trends.
- Explain at least two methods that can be used to develop, enhance, and evaluate STD surveillance systems.
- Summarize how at least two factors within the health services system can affect STD prevention and treatment services.
- Describe at least two social and behavioral aspects of STD prevention.
- Describe at least two examples of bridging scientific research and public health program management to enhance STD prevention and control efforts.
FACULTY/CREDENTIALS:
| Neetu Abad,PhD, Behavioral Scientist, Centers for Disease Control and Prevention, Atlanta, GADaren R. Anderson, MD, Director, Wetizman Institute, Community Health Center, Inc. Atlanta, GAGregory L. Armstrong, MD, Director, Centers for Disease Control and Prevention, Office of Advanced Molecular Detection, Atlanta, GALaura Hinkle Bachmann, MD, MPH, Professor of Medicine, Wake Forest University Health Sciences, Winston-Salem, NC Mary Travis Bassett, MD, MPH, José A. Bauermeister, PhD, MPH, Jose A. Bazan, DO, Susan Blank, MD, MPH, BS, Anna Bowen, MD, MPH, BS, Virginia (Ginny) Bowen, PhD, MHS, William Brand, MPH, Otis W. Brawley, MD, BS, John T. Brooks, MD, BA, Rebecca Brotman, PhD, MPH, BA, Sylvia B. Caley, JD, MBA, RN, BA, Mandy Carter, Joan M. Chow, DrPH, MPH, BA, Myron S. Cohen, MD, Clare Coleman, BA, Ryan Cramer, JD, MPH, Sheldon Danziger, PhD, BA, Demetre Daskalakis, MD, MPH, BA, Shireesa Dhanireddy, MD, Richard Dunville, MPH, Richard Elliott, LLM, LLB, BA Hons, Yetunde F. Fakile, PhD, MSc, BSc, Daniel Seth Fierer, MD, David N. Fredericks, MD, MS, BS, Matthew R. Golden, MD, MPH, BA, Jack Harrison-Quintana, MA, BS, Edward W. Hook III, MD, Katherine K. Hsu, MD, MPH, ScB, Aron Janssen, M.D., David H. Jernigan, PhD, AB, Rachel Kachur, MPH, BA, Nicholas J. Kassebaum, MD, BA, Rupert Kaul, MD, PhD, FRCP(C), Sarah Kidd, MD, MPH, BA, Michael Klompas, MD, MPH, Barbara Knust, DVM, MPH, Archana Bodas LaPollo, MPH, Kathy Le Backes, MPH, BS, Michael V. Maciosek, PhD, Bruce Maeder, BA, Lisa Manhart, PhD, MPH, BA, Jeanne Marrazzo, MD, Steven Martin, Ph.D., Eleanor Maticka-Tyndale, PhD, MA, BA, Sheena McCormack, MBBS, MSc, FRCP, Dip Ven, Jonathan Mermin, MD, MPH, AB, William C. Miller, MD, PhD, MPH, AB, Caroline Mitchell, MD, MPH, Christina A. Muzny, MD, MED, ID, Jean B. Patel, PhD, D(ABMM), BS, Tonia Poteat, PhD, MPH, PA-C, MMSc, BA, Asa Radix, MD, MPH, Catherine N. Rasberry, PhD, MCHES, MS, BS, Helen Rees, MD, Ellen D. B. Riggle, PhD, AM, BA, Jeanne S. Sheffield, MD, OB/GYN, MFM, BS, Bruce Baird Struminger, MD, MA, BA, Patrick Sullivan, PhD, DVM, David Trees, PhD, BS, Dan Wohlfeiler, MJ, MPH, BA, Jonathan Zenilman, MD, BA,
|
ORIGINATION DATE: September 20, 2016
EXPIRATION DATE: September 20, 2018
URL: https://www.cdc.gov/std/
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser
MATERIALS: None
TARGET AUDIENCE:
Administrators, CHES certified health Educators, DOs, Epidemiologists, Laboratorians, Physicians, Registered Nurses, Licensed practical/vocational nurses, MDs, Nurse practitioners, other health educators, Physician assistants, Program managers, Registered nurses
PREREQUISITES: The conference is open to anyone interested
in sexually transmitted diseases (STDs)
trends, screening, treatment, and prevention;
however, it is specifically designed for
physicians, scientists, public health officials,
community workers, clinicians, nurses,
program managers, and other professionals
who need STD treatment and prevention
information as part of their profession (i.e.,
programmatic, research, policy, clinical
practice, community-based practice.
FORMAT: Enduring Web-based
CONTACT INFORMATION: Sheila McKenzie
Division of STD Prevention, (404) 639-8357
ACCREDITATION STATEMENTS:
CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention, American Sexual Health Association, American Sexually Transmitted Disease Association, National Coalition of STD Directors
Pan American Health Organization, Public Health Agency of Canada, and
World Health Organization. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 18 AMA PRA Category 1 Credits™.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 17.4 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.9 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 16.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 20 CPH recertification credits for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, our content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of:
Laura Hinkle Bachmann, MD, MPH, Professor of Medicine, Wake Forest University Health Sciences, Winston-Salem, NC and she wishes to disclose serving as a Consultant on CDC Treatment Guidelines; CDC Clinical Services Guidelines.
Nicholas J. Kassebaum, MD, BA, Assistant Professor, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA and he wishes to disclose being a Consultant for Vifor Pharmaceuticals, Inc.
Jessica Ladd, MPH, PhD, BA, Founder & CEO, Sexual Health Innovations, San Francisco, CA and she wishes to disclose SHI has offered contract services to health departments in the past to help them serve their tech needs. The STD arm of the org is being shut down in the next year however so this will in no way be a sales pitch.
Lisa Manhart, PhD, MPH, BA, Professor, Department of Epidemiology University of Washington, Seattle, WA and she wishes to disclose Receipt of test kits and reagents from Hologic, Inc.
Caroline Mitchell, MD, MPH, Assistant Professor, Obstetrics, Gynecology & Reproductive Biology, Vincent Center for Reproductive Biology Massachusetts General Hospital, Boston, MA and she wishes to disclose serving on scientific advisory Boards for Perrigo Pharmaceuticals and Symbiomix.
Planning committee discussed conflict of interest with the following to ensure there is no bias: Laura Hinkle Bachmann, Nicholas J. Kassebaum, Jessica Ladd, Lisa Manhart, and Caroline Mitchell.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of:
Dr. Laura Hinkle Bachman’s discussion in Debate 2: Is it Okay if MSM Get STDs, Just Not HIV? She will be discussing Extragenital NAATS for oral and rectal GC and CT diagnosis.
Dr. Jeanne Marrazzo’s discussion in Debate 3: Are Use of non-microscopic BV POC tests sufficient for clinical management of BV? and Mini-Plenary 3: STD Prevention In The Context Of Biomedical Interventions To Prevent HIV And Unintended Pregnancy? Topic: Preventing HIV, STI, & unintended pregnancy in women at risk: evolving evidence & approach. She will be discussing review of recent clinical trials of products for biomedical HIV prevention that have not yet been approved (under investigational use).
Dr. Caroline Mitchell’s discussion in Debate 3: Are Use of non-microscopic BV POC tests sufficient for clinical management of BV? She will be discussing many diagnostic tests for BV that have not been FDA-approved.
Dr. Tonia Poteat’s discussion in Mini-Plenary 4: Understanding Gender Identity: Neurodevelopmental Underpinnings, Gender Fluidity, and Creating Better Outcomes for Sexual Minorities. Topic: Transgender Populations: Epidemiology and Best Practices in STD Prevention and Care. She will be discussing use of estrogen and androgen blockers for gender affirmation.
CDC did not accept commercial support for this continuing education activity.
To receive continuing education (CE):
Continuing education for this conference is only available through the CDC Training and Continuing Education Online system (CDC TCEO). Please follow the instructions provided below. You must complete the online evaluation between October 27, 2016 and October 24, 2018 to receive your continuing education or your certificate of completion.
To complete online evaluation:
- Go to CDC TCEO at https://www.cdc.gov/tceonline/. Select Participant Login to login. If you are new to TCEO, select New Participant to create a user ID and password.
- Once logged on to CDC TCEO, the Participant Services page will display. Select the Search and Register link. Select a search method to locate the conference and click on View.
- Click on the conference name, and the conference information page will display. Scroll down to Register Here. Select the type of CE that you would like to receive and then select Submit.
- The next page requests demographic information. New participants are required to answer the demographic questions. Returning participants please verify this information and select Submit.
- A message will display thanking you for registering for the conference. You will then be prompted to select the sessions that you would like to attend.
- After attending your selected conference sessions return to CDC TCEO. Select Participant Login to login.
- The Participant Services page will display. Select the Evaluations and Tests link. Select Conferences. The conference will be listed with the sessions you selected. You may Add/Edit Sessions until you have completed the evaluation for a particular session. After completing all of the session evaluations you will be prompted to complete the overall conference evaluation.
- A record of your conference completion and your CE certificate will be posted in the Transcript and Certificate section, located on the Participant Services page.
If you have any questions or problems contact:
CDC/ATSDR Training and Continuing Education Online
1-800-41TRAIN
Email at ce@cdc.gov
FEES: No fees are charged for CDC’s CE activities.